Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis

REFERENCES

• Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Bums CJ, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum. 1997;40(4):734–42.
   PubMedGoogle Scholar
• Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol. 1996;23(10):677–82.
   Google Scholar
• Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 2008;158(3):487–95.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994;37(6):902–6.
   Google Scholar
• Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al. Systemic sclerosis in childhood: clinical and immuno-logic features of 153 patients in an intemational database. Arthritis Rheum. 2006;54(12):3971–8.
   PubMedGoogle Scholar
• Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: clas-sification, clinical and serologic features, and survival in com-parison with adult onset disease. J Rheumatol. 2006;33(5): 1004–13.
   Google Scholar
• Foeldvari I. Update on pediatric systemic sclerosis: similarities and differences from adult disease. Curr Opin Rheumatol. 2008; 20(5):608–12.
   PubMedGoogle Scholar
• Czitjak L, Nagy Z, Szegedi G. Systemic sclerosis in the elderly. Clin Rheumatol. 1992;11(4):483–5.
   PubMedGoogle Scholar
• Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP, Campillo M, Fonollosa-Pla V, Vilardell-Tarres M. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford). 2010; 49(6):1112–7.
   PubMedGoogle Scholar
• Hugle T, Schuetz P, Daikeler T, Tyndall A, Matucci-Cerinic M, Walker UA, et al. Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford). 2011;50(1):161–5.
   Google Scholar
• Derk CT, Artlett CM, Jimenez SA. Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study. Clin Rheumatol. 2006;25(6):831–4.
   Google Scholar
• Manno RL, Wigley FM, Gelber AC, Hummers LK. Late-age onset systemic sclerosis. J Rheumatol. 2011;38(7):1317–25.
   PubMedGoogle Scholar
• Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in sclero-derma. Chest. 2003;124(6):2098–104.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Krieg T, Black C, Medsger TM, Fleischmajer R, Rowell N, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol. 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Subcommittee for Scleroderma Criteria of the American Rheu-matism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Clements P, Lachenbrush P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5.
   Google Scholar
• Steen VD, Powell DL, Medsger TAJ. Clinical correlations and prognosis based on serum autoantibodies in patients with sys-temic sclerosis. Arthritis Rheum. 1988;31:196–203.
   Google Scholar
• Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear anti-bodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37(1):75–83.
   Google Scholar
• Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35(1):35–42.
   PubMed Web of Science ®Google Scholar
• Aoyama K, Nagai Y, Endo Y, Ishikawa 0. Juvenile systemic sclerosis: report of three cases and review of Japanese published work. J Dermatol. 2007;34(9):658–61.
   Google Scholar
• Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000;9(2):96–100.
   Google Scholar
• Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford). 1999;38(3):228–34.
   PubMed Web of Science ®Google Scholar
• Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Balti-more). 1999;78(3):139–47.
   Google Scholar
• Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka 0, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66(6):754–63.
   Google Scholar
• Sunderkotter C, Herrgott I, Bruckner C, Moinzadeh P, Pfeiffer C, Gerss J, et al. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol. 2009;160(4):835–43.
   PubMedGoogle Scholar
• Chang B, Schachna L, White B, Wigley FM, Wise RA. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol. 2006;33(2):269–74.
   Google Scholar
• Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al. The three-year incidence of pulmonary arterial hyper-tension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60(6): 1831–9.
   PubMed Web of Science ®Google Scholar